The 2011 Leading Pharmaceutical Companies Product Portfolio Analyses

October 2010 | 275 pages | ID: L9EB0A95767EN
Venture Planning Group

Abstracts

Global PDF: US$ 3,900.00

For each company, the analyses present:

• Extensive review of major ethical, OTC, and generic drugs.
• Most recent new drug introductions and indications.

The companies analyzed in the report:

        -   AstraZeneca
        -   Bristol-Myers Squibb
        -   GlaxoSmithKline
        -   Johnson & Johnson
        -   Merck
        -   Novartis
        -   Pfizer
        -   Roche
        -   Sanofi-Aventis
        -   Wyeth

Contains 275 pages